Volume 7, supplement issue 1, July 2007
3rd International Conference on cGMP Generators, Effectors and Therapeutic Implications
120 articles in this issue
-
-
cGMP signaling pathway is involved in Leyding cell stress response
Authors (first, second and last of 5)
-
-
-
-
LPS-induced down-regulation of NO-sensitive guanylyl cyclase in astrocytes occurs by proteasomal degradation in nuclear bodies
Authors (first, second and last of 5)
-
Role of the sGC activator ataciguat sodium (HMR1766) in cardiovascular disease
Authors (first, second and last of 6)
-
Relaxant effect of BAY 41–2272 in the rabbit isolated detrusor smooth muscle (DSM): involvement of cGMP-independent mechanisms
Authors (first, second and last of 4)
-
-
-
Molecular modulators of cardiac stress targeted by PDE5 inhibition
Authors (first, second and last of 9)
-
-
-
Activation of soluble guanylate cyclase in the presence of purified human aldehyde dehydrogenases
Authors (first, second and last of 7)
-
-
-
-
Targeting heme-oxidized soluble guanylate cyclase with BAY 58-2667 in experimental heart failure
Authors (first, second and last of 6)
-
-
-
-
Run training ameliorates the established erectile dysfunction in rats under long-term nitric oxide (NO) blockade
Authors (first, second and last of 8)
-
-
Coadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure
Authors (first, second and last of 4)
-
-
Pharmacological characterization of the novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum
Authors (first, second and last of 7)
-
-
-
-
NO-induced motility effects in gastric fundus and pylorus of sGCβ1his105phe mutant mice
Authors (first, second and last of 5)
-
Transgenic mice with a NO-insensitive soluble guanylate cyclase
Authors (first, second and last of 6)
-
Reperfusion lung injury is attenuated by natriuretic peptide receptor antagonist in in-vivo mouse model
Authors (first, second and last of 7)
-
Guanylyl cyclase-A mediated endothelial actions of natriuretic peptides are critically involved in postischemic reperfusion
Authors (first, second and last of 7)
-
Chronic inhibition of cyclic GMP phosphodiesterase 5A may promote pressure overload-induced chamber dilatation in mice
Authors (first, second and last of 6)
-
Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients
Authors (first, second and last of 7)
-
Receptor guanylyl cyclase-G-deficient mice are protected against renal ischemia-reperfusion injury by preventing apoptosis and inflammation
Authors (first, second and last of 8)
-
-
Effect of new sildenafil analogues in the rabbit isolated aorta
Authors (first, second and last of 5)
-
-
-
-
-
-
Physiological and pathological effects of complete sGC deletion
Authors (first, second and last of 4)
-
-
Interstitial cells of Cajal in the urethra as effectors of the nitric oxide action through the cyclic GMP pathway
Authors (first, second and last of 4)
-
-
-
Specificity of commonly used cyclic nucleotides with PKA, PKG and Epac-implementing microcalorimetry to determine PDE activities
Authors (first, second and last of 11)
-
Design and synthesis of the first NO- and haem-independent sGC activator BAY 58–2667 for the treatment of acute decompensated heart failure
Authors (first, second and last of 8)
